Skip to main content

Pancuronium Side Effects

Medically reviewed by Last updated on Oct 12, 2023.

Applies to pancuronium: parenteral injection.


Side effects include:

Various degrees of skeletal muscle weakness.

For Healthcare Professionals

Applies to pancuronium: intravenous solution.


Uncommon (0.1% to 1%): Severe anaphylactic reactions[Ref]


Uncommon (0.1% to 1%): Pain and burning at injection site[Ref]


Frequency not reported: Prolonged paralysis, disuse atrophy, and areflexia have been reported with prolonged use of this drug[Ref]


Frequency not reported: Decreased intraocular pressure, miosis[Ref]


Rare (less than 0.1%): Bronchospasm, wheezing

Frequency not reported: Apnea, respiratory depression[Ref]


Very common (10% or more): Mild to moderate increase in blood pressure and/or pulse rate (10%)

Rare (less than 0.1%): Hypotension, cardiovascular collapse, flushing, edema, arrhythmia, bradycardia

Frequency not reported: Dysrhythmias, increased cardiac output[Ref]


Uncommon (0.1% to 1%): Transient rash, pruritus, redness[Ref]


Frequency not reported: Hypersalivation[Ref]

Frequently asked questions


1. Cerner Multum, Inc. UK Summary of Product Characteristics.

2. Cerner Multum, Inc. Australian Product Information.

3. Product Information. Pancuronium Bromide (pancuronium). Hospira Inc. 2018.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.